A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes Are Described
Clinical trial NCT04122976 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04122976
- Sponsor
- Bayer
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2020-01-30
- Primary completion
- 2026-07-20
- Enrollment
- 805
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.